Buy Divaza® lozenges 100 pcs
  • Buy Divaza® lozenges 100 pcs


Materia Medica
1285 Items
Dosage form
Brand & Manufacturer
Package Size
  • done All payments are SSL encrypted
  • done Full Refund if you haven't received your order
  • done International shipping to the USA, UK and Europe

Clinical Pharmacology

Pharmacological group: Antihypoxant, antioxidant, nootropic, angioprotective agent.
Pharmaceutical action: Divaza®a - a combined drug.
Antibodies to the brain-specific protein S-100 have an antioxidant, antihypoxant, neuroprotective, anxiolytic effect. Modify the functional activity of the protein S-100, carrying out the conjugation of information and metabolic processes in the brain. They have a membranotropic action, causing a decrease in amplitude and suppression of the generation of an action potential; modulate synaptic plasticity in the limbic structures of the brain, hippocampus, reticular formation; contribute to enhancing the inhibitory effects of GABA in the central nervous system. They exhibit sigma 1 receptor agonist properties in vitro.
Inhibit lipid peroxidation.
They have a normalizing effect on the integrative activity of the brain, which is manifested by a wide range of balanced psychopharmacological effects: antidepressant, anxiolytic, neuroprotective, antiasthenic, antiamnesic.
Antibodies to endothelial NO-synthase increase the activity of the enzyme endothelial NO-synthase, restore the production of endothelium nitric oxide (NO), eliminate endothelial dysfunction, have an endothelium-protective effect, affect NO-dependent vasodilation.
Experimentally shown stimulating effect of Divaza® on reparative processes in the focus of ischemic brain damage.
The combined use of the drug components is accompanied by an increase in the neuroprotective activity of antibodies to S-100 protein, an increase in the vegetative stabilizing effect, normalization of the vegetative status, a synergistic effect of both components on neuronal plasticity and, consequently, an increase in brain resistance to toxic effects; improves the integrative activity and restores the inter-hemispheric connections of the brain, helps to eliminate cognitive impairments, stimulates reparative processes and accelerates the restoration of the functions of the central nervous system, improves mental performance, restores the learning and memory processes, normalizes somatovegetative manifestations, increases cerebral blood flow.
Divaza®a, as well as its components, does not have a sedative and muscle relaxant effect, does not cause addiction and addiction.
Pharmacokinetics: The sensitivity of modern physico-chemical methods of analysis (gas-liquid chromatography, high-performance liquid chromatography, chromatography-mass spectrometry) does not allow to evaluate the content of ultra-low doses of antibodies in biological fluids, organs and tissues, which makes it technically impossible to study the pharmacokinetics of the drug Divaza®.


In the complex therapy:
- restoration of the integrative activity of the brain in a wide range of organic disorders of the central nervous system, including caused by neurodegenerative diseases, cerebrovascular (including ischemic) diseases, neuroinfections, brain injury
- somatoform dysfunction of the autonomic nervous system.


1 tab .:
- antibodies to the brain-specific protein S-100 affinity purified * 0.006 g
- antibodies to endothelial NO-synthase affinity purified * 0,006 g
excipients: lactose monohydrate; MCC; magnesium stearate.

No customer reviews for the moment.

Write your review

Write your review


Dosage and Administration

For oral use.
At one time - 1 tab. (keep in mouth until completely dissolved). Take 1-2 tables. 3 times a day out of meals. Depending on the severity of the condition, in the acute period, the frequency of administration can be increased up to 4-6 times per day.
With pronounced organic lesions of the central nervous system, the duration of a course of therapy may reach 4-6 months

Adverse reactions

Possible reactions increased individual sensitivity to the components of the drug.


increased individual sensitivity to the components of the drug Divaza®;
patients under 18 years of age, due to the lack of data on the effectiveness and safety for this age.

Drug interactions

Cases of incompatibility with other drugs have not yet been registered.

Special instructions

The preparation contains lactose, and therefore it is not recommended to prescribe it to patients with congenital galactosemia, glucose malabsorption or galactose syndrome, or in congenital lactase deficiency.
Influence on ability to steer vehicles and work with mechanisms. Divaza®a does not affect the ability to drive vehicles and other potentially dangerous machinery.


Symptoms: dyspeptic symptoms are possible, due to the fillers contained in Divaza® preparation.

  • Brand name: Divaza®
  • Active ingredient: Homeopathic composition
  • Dosage form: pills for sucking.
  • Manufacturer: Materia Medica
  • Country of Origin: Russia

Customers who bought this product also bought:


Price $22.94

8 other products in the same category: